SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

Escalating US-Israeli strikes on Iran are fueling intense community discussion around USO, with many anticipating significant oil price spikes and a global supply shock as shipping through the vital Strait of Hormuz faces increasing disruptions.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is surging as escalating Middle East tensions, including strikes on oil infrastructure and disruptions to the Strait of Hormuz, fuel community expectations of significant oil price spikes and a massive upward move for the sector.

Codatta

Codatta (XNY) is trending as the crypto community highlights its impressive price resilience and ability to show strength even during broader market pullbacks, leading to active discussions around its consistent breaking of resistance and establishing new support levels for potential further upside.

ProShares Trust - ProShares Ultra Gold 2x Shares

ProShares Ultra Gold

UGL is trending as escalating geopolitical uncertainties and concerns over ongoing fiat currency debasement spur significant safe-haven demand, with the community actively discussing gold's strong upward momentum and the broader precious metals rally.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating Middle East tensions, including strikes on Iran and concerns over disruptions in the vital Strait of Hormuz, are driving a surge in crude oil prices and fueling community discussion around Indonesia Energy Corp Ltd's potential for a significant short squeeze given its low float.

OR Royalties, Inc. engages in the acquisition, mining, and exploration of precious metals, streams, and other royalties. It holds interests in the Canadian Malartic mine. The company was founded on April 29, 2014 and is headquartered in Montreal, Canada.

OR Royalties Inc.

Osisko Gold Royalties Ltd

Osisko Gold Royalties is attracting significant community interest following its joint acquisition of a major gold stream on SolGold's Cascabel project and the emergence of activist investor Elliott Management as a large stakeholder. This news, combined with robust preliminary Q2 results showcasing record cash margins, reinforces bullish sentiment for the stable gold royalty player.

The centrifuge token model powers centrifuge, providing the framework needed to run the platform without reliance on a single point of failure, including the centrifuge team or Company, and to accelerate its utility. To accomplish this, centrifuge leverages the cryptoeconomic primitives of a native token called the centrifuge token (cfg), a nominated-proof-of-stake consensus algorithm that employs centrifuge to stake value, rewards for centrifuge adoption, and an on-chain governance mechanism that empowers centrifuge holders to guide the development of centrifuge.

Centrifuge

Centrifuge is trending following the launch of the world's first licensed S&P 500 Index Fund Token, a development hailed by the community as a monumental step for institutional adoption and a significant advancement in tokenizing real-world assets.

Cenovus Energy, Inc. is a Canadian-based integrated energy company, which engages in the provision of gas and oil. It operates through the following segments: Upstream, Downstream, and Corporate and Eliminations. The Upstream segment refers to operations of oil sands, conventional, and offshore. The Downstream segment operates the Canadian and U.S. refining. The Corporate and Eliminations segment includes the corporates costs for general and administrative. The company was founded in 1881 and is headquartered in Calgary, Canada.

Cenovus Energy Inc

Cenovus Energy is trending as discussions focus on the new Canadian government deal to build a West Coast oil pipeline, poised to diversify export markets and reduce reliance on the U.S. The community is weighing CVE's strong operational execution and strategic acquisitions against its oil price sensitivity and current valuation, anticipating enhanced shareholder returns and long-term growth in a robust global energy market.

SPX6900 is an advanced blockchain cryptography token coin capable of limitless possibilities and scientific utilization.

SPX6900

SPX CRYPTO is trending due to a highly engaged community consistently dollar-cost averaging into the "S&P 6900" with a fervent belief in its potential for exponential growth. The community views it as a disruptive "pure belief asset" within the crypto market, aiming to "flip the stock market" akin to early Bitcoin or GameStop.

Wheaton Precious Metals Corp. is a precious metals streaming company with the quality portfolio of long-life, low-cost assets. Its business model offers investors commodity price leverage and exploration upside but with a much lower risk profile than a traditional mining company. It operates through the following business segments: Gold, Silver, Palladium, Cobalt, and Other. Wheaton was founded by Peter Derek Barnes on December 17, 2004 and is headquartered in Vancouver, Canada.

Wheaton Precious Metals Corp

Wheaton Precious Metals is gaining attention amid soaring gold prices reaching all-time highs and silver breaking multi-decade resistance, amplifying interest in its asset-light streaming model. The community is discussing recent strong earnings, a robust balance sheet, and a series of analyst target increases, though some express skepticism about its short-term price movements relative to the broader precious metals sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What is Lifesci Capital's Estimate for LRMR FY2025 Earnings?

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) - Equities researchers at Lifesci Capital issued their FY2025 EPS estimates for Larimar Therapeutics in a note issued to investors on Tuesday...

<ul class="summary-bullets"><li>Wall Street looks set for a cautious open despite Nvidia’s strong quarter, with traders focused on China exposure.</li><li>Warner Bros. Discovery is set to report earnings before the bell.&nbsp;</li><li>On the macro front, investors will parse weekly jobless claims at 8:30 a.m. ET.&nbsp;</li></ul>U.S. stock futures were mixed early Thursday, with traders bracing for a choppy session. While AI bellwether Nvidia delivered a blowout earnings report, concerns over its access to the Chinese market, along with disappointing guidance from software giants like Salesforce and C3.ai, are weighing on investor sentiment.Investors will also be watching for developments as the U.S. and Iran hold their latest round of talks in Geneva today amid military threats.&nbsp;As of 3:00 a.m. ET on Thursday, Nasdaq futures were down 0.1%, Dow futures were down 0.2%, and S&amp;P 500 and Russell 2000 futures were flat, with a positive bias.Meanwhile, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, has flipped to ‘bullish’ from ‘neutral’ a day ago, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has remained ‘bearish’ amid high message volumes.&nbsp;Trending Stocks To WatchNvidia (NVDA):&nbsp;It was the top trending ticker on Stocktwits at the time of writing. The stock pared its gains in after-hours trading as concerns over China's revenue outlook lingered. CFO Colette Kress confirmed that the current forecasts exclude China revenue. This comes even as the chipmaker has secured a license to ship a small number of its less advanced H200 chips to Beijing, subject to inspection and a 25% duty.&nbsp; Netflix (NFLX), Warner Bros Discovery (WBD) &amp; Paramount (PSKY):&nbsp;Investors are closely tracking the developments in the merger drama, with traders speculating that the streamer may walk away from its bid for Warner Bros. Discovery. Paramount has now upped its stakes with a $31/share offer, while Netflix's co-CEO is reportedly heading to White House to discuss the merger’s regulatory issues. Also, keep an eye on WBD, which reports earnings today.&nbsp;Salesforce (CRW):&nbsp;The software giant’s fiscal 2027 revenue guidance missed Wall Street’s expectations, overshadowing its strong Q4 earnings report.&nbsp;C3.ai (AI):&nbsp;A wider-than-expected loss and announcement of workforce cuts is weighing on trader sentiment.&nbsp;Apple (AAPL):&nbsp;Report suggest that the iPhone maker is in talks with major Indian banks to launch its payments service in India by mid-2026.&nbsp;Larimar Therapeutics Inc. (LRMR):&nbsp;The pharma company has priced an upsized $100 million stock offering. The deal was upsized from the earlier-announced $75 million offering and comes after the FDA’s Breakthrough Therapy designation for Nomlabofusp, earlier this week. It was among the top trending tickers on Stocktwits at the time of writing.&nbsp;ImmunityBio Inc. (IBRX):&nbsp;The retail favourite pharma stock remains in focus ahead of the ASCO Genitourinary Cancers Symposium (Feb. 26–28).&nbsp;Watch out for rare-earth stocks in trade today (CRML, MP, UUUU), following a report that suppliers to U.S. aerospace and semiconductor firms are reporting worsening shortages in the market.&nbsp;And copper stocks (FCX, RIO, SCCO, HBM) could see some actiontoday, with copper futures on track for their seventh straight monthly advance.&nbsp; Other tickers trending on Stocktwits at the time of writing included Snap Inc (SNAP), Trade Desk Inc (TTD), Joby Aviation (JOBY), and Sarepta Therapeutics (SRPT), among others.&nbsp;Other Catalysts To WatchOn the economic front, investors will monitor the weekly jobless claims release at 8:30 am. Also, Federal Reserve Vice Chair for Supervision Michelle Bowman is scheduled to testify before Congress later today.&nbsp; On the earnings radar, investors will be watching for the quarterly reports from Warner Bros. Discovery (WBD), Baidu (BIDU), Celsius (CELH), Shake Shack (SHAK), and J.M. Smucker (SJM), among others, before the bell today. Notable companies reporting earnings after market close include Intuit (INTU), Dell Technologies (DELL), TeraWulf (WULF), Rocket Lab (RKLB), and SoundHound AI (SOUN), among others.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Tread Caution On Nvidia’s China Risk: Why NFLX, WBD, AAPL, CRM, AI, LRMR Are On Traders' Radar Today

Data from Stocktwits showed that retail sentiment on SPY and QQQ diverged. 

Equity

<ul class="summary-bullets"><li>The company priced an upsized $100 million stock offering, following a record 61% surge in Wednesday’s regular session.</li><li>On Tuesday, the FDA granted Breakthrough Therapy Designation to Nomlabofusp, Larimar’s frataxin protein replacement therapy for Friedreich’s ataxia.</li><li>The company remains on track to submit a BLA in June and expects topline data in Q2.</li></ul>Shares of Larimar Therapeutics Inc. (LRMR) surged over 60% on Wednesday to their strongest session on record before pricing an upsized $100 million stock offering, extending gains following the FDA’s Breakthrough Therapy designation for Nomlabofusp.<h2 class="st-heading-2">Larimar Prices Upsized $100M Stock Offering</h2>Late Wednesday, the biotech firm said it priced 20 million shares of common stock at $5 per share, raising gross proceeds of nearly $100 million before underwriting discounts and expenses.The deal was upsized from the earlier-announced $75 million offering. Larimar also granted underwriters a 30-day option to purchase up to an additional 3 million shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on Thursday.Larimar intends to use the net proceeds to support the development of Nomlabofusp, its Breakthrough Therapy-designated frataxin protein replacement treatment for a neurodegenerative disorder, as well as working capital and general corporate purposes, including research and development and commercialization expenses.<h2 class="st-heading-2">FDA Grants Breakthrough Status To Nomlabofusp</h2>The equity raise comes just one day after Larimar said that the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-larimar-therapeutics-stock-surge-pre-market-today/cZRvC02R4CO">FDA granted</a> Breakthrough Therapy Designation to Nomlabofusp, its frataxin protein replacement therapy for adults and children with Friedreich’s ataxia, a rare inherited neurodegenerative disorder.The designation is intended to expedite development and regulatory review for therapies that may offer substantial improvement over available treatments.The FDA’s decision was based on preliminary data from Larimar’s ongoing open-label study. The company said treatment raised frataxin levels in patients’ skin to amounts typically seen in people who carry the gene mutation but do not develop symptoms. After one year, patients also showed consistent improvement across four key measures of the disease, including overall neurological function, daily living activities, hand coordination and fatigue.The agency also reaffirmed its willingness to consider skin frataxin levels as a novel surrogate endpoint reasonably likely to predict clinical benefit, supporting Larimar’s planned Biologics License Application (BLA) seeking accelerated approval.<h2 class="st-heading-2">BLA Timeline And Phase 3 Plans Remain On Track</h2>Larimar said it remains on track to submit a BLA in June. Topline data from the open-label study to support the filing are expected in the second quarter of this year.The company also plans to initiate screening in a global confirmatory Phase 3 study in the second quarter of 2026, with first patient dosing expected by mid-2026. If approved, a U.S. launch is targeted for the first half of 2027.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for LRMR was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/lrmr_ss_png_14eb5c6335.webp" alt="lrmr ss.png" width="968" height="143"><figcaption>LRMR sentiment and message volume as of February 25 | Source: Stocktwits</figcaption></figure>One user said, “back at $6 hope to open at $7-$8 tomorrow.”<stembedurl>https://stocktwits.com/Fa07/message/645927469</stembedurl>Another user said, “They’ll get this drug pushed through and the share price will be 15-20 very soon.”<stembedurl>https://stocktwits.com/mrtallman/message/645936108</stembedurl><a href="https://stocktwits.com/symbol/LRMR">LRMR stock</a> has jumped 56% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

LRMR stock has jumped 56% year to date. (Photo credit: Getty Images)

Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy

Larimar (LRMR) company priced 20 million shares at $5 each, upsized from a previously announced $75 million raise.

The company priced 20 million shares at $5 each, upsized from a previously announced $75 million raise.

Best Small Cap Stocks To Follow Today - February 25th

Larimar Therapeutics, AltC Acquisition, XWELL, Direxion Daily PLTR Bear 1X Shares, and Vale are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap...

Citigroup Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $14.00

Citigroup upped their target price on Larimar Therapeutics from $12.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday...

Larimar Therapeutics (NASDAQ:LRMR) Hits New 1-Year High After Analyst Upgrade

Larimar Therapeutics (NASDAQ:LRMR) Sets New 12-Month High on Analyst Upgrade...

Biotech Stocks To Follow Today - February 25th

ImmunityBio, Larimar Therapeutics, and United Therapeutics are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded...

Larimar Therapeutics Sees Unusually High Options Volume (NASDAQ:LRMR)

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) was the target of some unusual options trading on Wednesday. Traders acquired 3,744 call options on the company. This represents an increase...

Larimar Therapeutics' (LRMR) Outperform Rating Reaffirmed at Wedbush

Wedbush reaffirmed an "outperform" rating and issued a $11.00 price objective on shares of Larimar Therapeutics in a research note on Wednesday...

Lifesci Capital Upgrades Larimar Therapeutics (NASDAQ:LRMR) to "Strong-Buy"

Lifesci Capital upgraded Larimar Therapeutics to a "strong-buy" rating in a research note on Tuesday...

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$5.31
Prev Close	$5.52
Open	$5.54
Dividend Yield	0.00%
50-Day Moving Average	$3.57
Beta	1.62
Avg. Volume	1.28M
PE Ratio	-2.75

52-Week High	$6.42
52-Week Low	$1.61
Market Capitalization	$454.48M
EPS (Annual)	-$1.32
Price to Book	3.27
Revenue Per Employee	$0.00

LRMR
Larimar Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LRMR News

LRMRLarimar Therapeutics Inc